BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 26427353)

  • 1. Early response as shown by enhancement of transglutaminase 1 expression after cisplatin-induced acute kidney injury.
    Furukawa K; Yamane M; Tatsukawa H; Hitomi K
    Arch Biochem Biophys; 2015 Nov; 586():27-32. PubMed ID: 26427353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin-induced oxidative stress stimulates renal Fas ligand shedding.
    Soni H; Kaminski D; Gangaraju R; Adebiyi A
    Ren Fail; 2018 Nov; 40(1):314-322. PubMed ID: 29619879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sub-nephrotoxic cisplatin sensitizes rats to acute renal failure and increases urinary excretion of fumarylacetoacetase.
    Vicente-Vicente L; Sánchez-Juanes F; García-Sánchez O; Blanco-Gozalo V; Pescador M; Sevilla MA; González-Buitrago JM; López-Hernández FJ; López-Novoa JM; Morales AI
    Toxicol Lett; 2015 Apr; 234(2):99-109. PubMed ID: 25677510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPAR-alpha ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G.
    Li S; Basnakian A; Bhatt R; Megyesi J; Gokden N; Shah SV; Portilla D
    Am J Physiol Renal Physiol; 2004 Nov; 287(5):F990-8. PubMed ID: 15280156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cisplatin-induced injury in human kidney organoids.
    Digby JLM; Vanichapol T; Przepiorski A; Davidson AJ; Sander V
    Am J Physiol Renal Physiol; 2020 Apr; 318(4):F971-F978. PubMed ID: 32150447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of ginsenoside-Rd in cisplatin-induced acute renal failure.
    Yokozawa T; Liu ZW
    Ren Fail; 2000 Mar; 22(2):115-27. PubMed ID: 10803758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomic study of cisplatin-induced nephrotoxicity.
    Portilla D; Li S; Nagothu KK; Megyesi J; Kaissling B; Schnackenberg L; Safirstein RL; Beger RD
    Kidney Int; 2006 Jun; 69(12):2194-204. PubMed ID: 16672910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiscale Mathematical Model of Drug-Induced Proximal Tubule Injury: Linking Urinary Biomarkers to Epithelial Cell Injury and Renal Dysfunction.
    Gebremichael Y; Lu J; Shankaran H; Helmlinger G; Mettetal J; Hallow KM
    Toxicol Sci; 2018 Mar; 162(1):200-211. PubMed ID: 29126144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative nephrotoxicity of cisplatin and new octahedral Pt(IV) complexes.
    Kim WK; Kwon YE
    Cancer Chemother Pharmacol; 2007 Jul; 60(2):237-43. PubMed ID: 17089165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feline chronic kidney disease is associated with upregulation of transglutaminase 2: a collagen cross-linking enzyme.
    Sánchez-Lara AC; Elliott J; Syme HM; Brown CA; Haylor JL
    Vet Pathol; 2015 May; 52(3):513-23. PubMed ID: 25047228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary cystatin C as a biomarker for acute kidney injury and its immunohistochemical localization in kidney in the CDDP-treated rats.
    Togashi Y; Sakaguchi Y; Miyamoto M; Miyamoto Y
    Exp Toxicol Pathol; 2012 Nov; 64(7-8):797-805. PubMed ID: 21377848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endotoxin and cisplatin synergistically induce renal dysfunction and cytokine production in mice.
    Ramesh G; Zhang B; Uematsu S; Akira S; Reeves WB
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F325-32. PubMed ID: 17494092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of elevated serum uric acid on cisplatin-induced acute renal failure.
    Roncal CA; Mu W; Croker B; Reungjui S; Ouyang X; Tabah-Fisch I; Johnson RJ; Ejaz AA
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F116-22. PubMed ID: 17210794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats.
    Fisch S; Liao R; Hsiao LL; Lu T
    J Vis Exp; 2016 Mar; (109):. PubMed ID: 27022768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury.
    Salahudeen AK; Haider N; Jenkins J; Joshi M; Patel H; Huang H; Yang M; Zhe H
    Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1354-65. PubMed ID: 18385271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. gamma-Glutamyl transpeptidase excretion in cisplatin-induced acute renal failure.
    Gordon JA; Gattone VH; Schoolwerth AC
    Am J Kidney Dis; 1986 Jul; 8(1):18-25. PubMed ID: 2873743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TauT protects against cisplatin-induced acute kidney injury (AKI) established in a TauT transgenic mice model.
    Han X; Chesney RW
    Adv Exp Med Biol; 2009; 643():113-22. PubMed ID: 19239142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin nephrotoxicity and protection by silibinin.
    Gaedeke J; Fels LM; Bokemeyer C; Mengs U; Stolte H; Lentzen H
    Nephrol Dial Transplant; 1996 Jan; 11(1):55-62. PubMed ID: 8649653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related differences in kidney injury biomarkers induced by cisplatin.
    Shin YJ; Kim TH; Won AJ; Jung JY; Kwack SJ; Kacew S; Chung KH; Lee BM; Kim HS
    Environ Toxicol Pharmacol; 2014 May; 37(3):1028-39. PubMed ID: 24751685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin-induced acute renal failure in mice is mediated by chymase-activated angiotensin-aldosterone system and interleukin-18.
    Okui S; Yamamoto H; Li W; Gamachi N; Fujita Y; Kashiwamura S; Miura D; Takai S; Miyazaki M; Urade M; Okamura H; Ueda H
    Eur J Pharmacol; 2012 Jun; 685(1-3):149-55. PubMed ID: 22543082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.